SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Speculating in Takeover Targets
CTG 8.400-2.2%Jan 18 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: richardred7/20/2010 1:17:32 PM
  Read Replies (2) of 6147
 
MATK-Martek Biosciences Corp-New buy order filled for this board. I've followed it for quite some time. I've also owned this one before. I sold it in the mid thirties. I didn't consider it a target before. The sales growth that has occurred and the current valuation now IMO give it speculative appeal along with longer term potential stock appreciation. Message 24521954. Earning were above expectations for the latest quarter. The company just announced they will have to take some charges for the closing of a plant. The company is trying to grow their non formula business to diversify away from the formula market. Matk just bought a company to do just that. DHA for food is the future and MATK is a big player.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext